0,894  0,003  GST A substrate
0,773  0,015  Caspase 9 stimulant
0,763  0,004  Platelet antagonist
0,676  0,002  GST M1-1 substrate
0,665  0,005  Platelet aggregation inhibitor
0,654  0,003  GST P1-1 substrate
0,651  0,012  Cholesterol antagonist
0,646  0,011  Vasodilator, peripheral
0,612  0,009  Eye irritation, high
0,597  0,009  Ulceration
0,582  0,009  Skin irritative effect
0,587  0,016  Antiallergic
0,577  0,012  Apoptosis antagonist
0,577  0,014  Antipruritic, allergic
0,565  0,014  Cardiovascular analeptic
0,554  0,009  Antiglaucomic
0,555  0,011  FMO1 substrate
0,567  0,031  TNF expression inhibitor
0,546  0,015  Lipoprotein disorders treatment
0,534  0,006  Anesthetic general
0,536  0,018  CTGF expression inhibitor
0,524  0,007  Antiulcerative
0,505  0,004  GABA C receptor agonist
0,528  0,029  Teratogen
0,517  0,022  GABA C receptor rho-3 antagonist
0,521  0,026  5 Hydroxytryptamine release inhibitor
0,515  0,021  Sensitization
0,512  0,027  Antithrombotic
0,494  0,012  Antidiabetic symptomatic
0,485  0,005  5 Hydroxytryptamine uptake stimulant
0,511  0,031  Aldehyde oxidase inhibitor
0,506  0,028  Respiratory analeptic
0,507  0,030  Embryotoxic
0,540  0,063  Apoptosis agonist
0,483  0,008  Septic shock treatment
0,488  0,014  Hypolipemic
0,496  0,023  Analeptic
0,497  0,028  5 Hydroxytryptamine release stimulant
0,472  0,007  Abortion inducer
0,537  0,073  Antiinflammatory
0,490  0,036  Immunosuppressant
0,459  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,485  0,034  Histamine release inhibitor
0,480  0,036  Calcium channel L-type activator
0,461  0,018  UGT2B4 substrate
0,469  0,026  Radioprotector
0,469  0,027  Cardioprotectant
0,456  0,014  Antihypoxic
0,442  0,004  Carcinogenic, group 1
0,449  0,016  Vasodilator
0,442  0,013  Calcium channel activator
0,443  0,016  Radiosensitizer
0,450  0,027  NOS3 expression inhibitor
0,424  0,006  Tyrosine 3 hydroxylase inhibitor
0,452  0,033  Antihypercholesterolemic
0,417  0,007  Protein kinase stimulant
0,418  0,008  Antipruritic, non-allergic
0,445  0,042  Stroke treatment
0,405  0,003  Photosensitizer
0,408  0,010  Phospholipase C inhibitor
0,422  0,024  DNA damaging
0,416  0,019  Angiogenesis stimulant
0,408  0,017  RNA-directed DNA polymerase inhibitor
0,415  0,024  Tumour necrosis factor alpha release inhibitor
0,414  0,029  Interleukin antagonist
0,410  0,026  Antipyretic
0,435  0,051  Atherosclerosis treatment
0,401  0,018  FMO3 substrate
0,403  0,020  Peroxidase inhibitor
0,394  0,013  Diabetic retinopathy treatment
0,392  0,012  Carcinogenic, group 3
0,409  0,030  NOS2 expression inhibitor
0,411  0,033  Chemoprotective
0,401  0,022  Psychostimulant
0,412  0,035  ICAM1 expression inhibitor
0,393  0,016  Antimutagenic
0,430  0,053  CYP2C9 substrate
0,387  0,013  Platelet adhesion inhibitor
0,399  0,028  Hypoglycemic
0,391  0,024  Myocardial infarction treatment
0,404  0,043  Immunomodulator
0,396  0,036  UGT1A9 substrate
0,363  0,004  Catalase inhibitor
0,364  0,005  Succinate dehydrogenase inhibitor
0,369  0,012  VCAM1 expression inhibitor
0,380  0,024  DNA synthesis inhibitor
0,364  0,008  Gastrin inhibitor
0,397  0,046  Antifungal
0,381  0,030  Superoxide dismutase inhibitor
0,373  0,023  Interleukin agonist
0,390  0,042  Antiischemic
0,366  0,021  Growth hormone agonist
0,388  0,043  CYP2C19 substrate
0,406  0,062  Transcription factor NF kappa B inhibitor
0,368  0,026  Antihypertriglyceridemic
0,391  0,052  Immunostimulant
0,368  0,030  UGT1A6 substrate
0,380  0,047  Antihypertensive
0,362  0,030  Insulysin inhibitor
0,374  0,044  Vasodilator, coronary
0,371  0,041  Antioxidant
0,336  0,006  Interleukin 4 antagonist
0,368  0,038  Cytostatic
0,336  0,011  Interleukin 6 antagonist
0,349  0,025  Sedative
0,411  0,087  Antiarthritic
0,333  0,009  DNA polymerase I inhibitor
0,338  0,015  Interferon gamma antagonist
0,331  0,009  Aldehyde dehydrogenase inhibitor
0,412  0,090  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,353  0,032  Vascular (periferal) disease treatment
0,336  0,017  Anesthetic
0,355  0,036  Cardiodepressant
0,356  0,037  Free radical scavenger
0,387  0,069  CYP2C19 inhibitor
0,350  0,033  Antiparasitic
0,324  0,008  Cystathionine beta-synthase inhibitor
0,331  0,015  Acaricide
0,349  0,034  Antineoplastic (liver cancer)
0,335  0,022  Non-steroidal antiinflammatory agent
0,318  0,005  Antieczematic
0,323  0,013  Antihelmintic (Nematodes)
0,338  0,029  Cyclic AMP phosphodiesterase inhibitor
0,314  0,007  Excitatory amino acid transporter EAAC1 inhibitor
0,307  0,005  Carbonic anhydrase III inhibitor
0,320  0,018  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,338  0,036  Flavin-containing monooxygenase substrate
0,307  0,006  Adenylate kinase inhibitor
0,357  0,057  Hepatic disorders treatment
0,317  0,018  Hair growth stimulant
0,336  0,040  Carcinogenic
0,314  0,019  Skeletal muscle relaxant
0,302  0,007  Ferrochelatase inhibitor
0,336  0,043  Proliferative diseases treatment
0,314  0,022  DNA methyltransferase I inhibitor
0,298  0,005  Catenin beta inhibitor
0,308  0,016  Tumour necrosis factor antagonist
0,311  0,019  Restenosis treatment
0,317  0,025  Hepatoprotectant
0,350  0,059  Caspase 3 stimulant
0,338  0,048  Sodium/bile acid cotransporter inhibitor
0,296  0,006  Histidine decarboxylase inhibitor
0,293  0,005  Toll-Like receptor 2 antagonist
0,294  0,006  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,326  0,042  Transcription factor STAT3 inhibitor
0,309  0,025  DNA methylase inhibitor
0,283  0,003  Fumarate hydratase inhibitor
0,294  0,015  Corneal wound healing stimulator
0,308  0,030  Muscle relaxant
0,338  0,061  Antipsoriatic
0,281  0,007  Antineoplastic, alkylator
0,280  0,007  UGT2B10 substrate
0,296  0,023  Antiseptic
0,274  0,003  Toll-Like receptor 4 antagonist
0,288  0,018  Insulin sensitizer
0,304  0,035  Antiparkinsonian, rigidity relieving
0,278  0,010  Uterine stimulant
0,325  0,058  Interleukin 2 agonist
0,275  0,008  GABA C receptor rho-2 antagonist
0,284  0,017  Antidote
0,280  0,017  Phospholipase A2 inhibitor
0,322  0,061  Lipoxygenase inhibitor
0,317  0,056  Antineoplastic (endocrine cancer)
0,264  0,005  Antirickettsial
0,286  0,027  Pneumotoxic
0,266  0,008  Carbonic anhydrase VI inhibitor
0,273  0,016  Glutathione S-transferase substrate
0,264  0,008  Carbonic anhydrase XIII inhibitor
0,307  0,052  Transcription factor STAT inhibitor
0,262  0,007  Glutamate dehydrogenase inhibitor
0,297  0,045  Mutagenic
0,296  0,044  Antineoplastic (lymphocytic leukemia)
0,286  0,035  Antihelmintic
0,315  0,064  Spasmolytic
0,273  0,023  Muscular dystrophy treatment
0,281  0,031  UGT2B7 substrate
0,256  0,006  Triose-phosphate isomerase inhibitor
0,253  0,004  Glutamate release inhibitor
0,259  0,011  Phobic disorders treatment
0,253  0,007  Raynaud's phenomenon treatment
0,272  0,027  CYP2B6 inhibitor
0,250  0,005  Alcohol oxidase inhibitor
0,334  0,091  Toll-Like receptor agonist
0,258  0,016  Alkylator
0,248  0,006  Arachidonic acid antagonist
0,246  0,004  GST T1-1 substrate
0,286  0,044  Chemopreventive
0,249  0,008  Phosphofructokinase-1 inhibitor
0,244  0,005  Thioredoxin inhibitor
0,241  0,003  Aconitate hydratase inhibitor
0,259  0,020  Pancreatic disorders treatment
0,365  0,128  Antineoplastic (solid tumors)
0,251  0,015  Cell adhesion inhibitor
0,239  0,004  Acetylcholine release stimulant
0,240  0,005  Folate antagonist
0,257  0,024  Bone formation stimulant
0,241  0,008  Coagulant
0,237  0,005  Interleukin 12 antagonist
0,259  0,028  Antiviral (West Nile virus)
0,238  0,007  GABA C receptor antagonist
0,259  0,029  Protein-tyrosine phosphatase inhibitor
0,267  0,037  P-glycoprotein inhibitor
0,261  0,031  Thrombolytic
0,241  0,014  Expectorant
0,241  0,015  Antiviral (Ebola)
0,229  0,005  GABA C receptor rho-1 antagonist
0,243  0,019  Antifungal enhancer
0,227  0,004  Glycine receptor agonist
0,234  0,010  Antispirochetal
0,255  0,032  Lipocortins synthesis antagonist
0,228  0,005  Adenylate cyclase stimulant
0,238  0,017  ATPase inhibitor
0,251  0,030  UGT1A3 substrate
0,252  0,031  Nitric-oxide synthase stimulant
0,346  0,125  Antidiabetic
0,346  0,125  Cyclophilin D inhibitor
0,314  0,093  CYP3A4 substrate
0,229  0,009  Porphobilinogen synthase inhibitor
0,239  0,020  Antihyperlipoproteinemic
0,331  0,113  Antibacterial
0,237  0,019  Antineoplastic antimetabolite
0,254  0,036  Neurotrophic factor enhancer
0,226  0,009  Mucolytic
0,328  0,112  15-Lipoxygenase inhibitor
0,233  0,020  Toll-Like receptor antagonist
0,219  0,006  Carbamoyl phosphate synthetase inhibitor
0,252  0,040  UGT1A4 substrate
0,298  0,087  Bone diseases treatment
0,230  0,021  Cholesterol synthesis inhibitor
0,259  0,049  Antihypotensive
0,214  0,006  Glutamate decarboxylase inhibitor
0,213  0,005  Interferon agonist
0,221  0,013  Choleretic
0,239  0,031  Amylase inhibitor
0,265  0,058  Cytotoxic
0,210  0,005  Antidote, mercury
0,207  0,002  Anesthetic inhalation
0,215  0,012  Calcium antagonist
0,254  0,050  Nitric oxide antagonist
0,206  0,003  Ca2+-transporting ATPase inhibitor
0,206  0,004  Antifungal (Pneumocystis)
0,234  0,031  Melanin inhibitor
0,206  0,004  GABA aminotransferase inhibitor
0,216  0,014  Cyclooxygenase 3 inhibitor
0,257  0,056  Amyloid beta aggregation inhibitor
0,210  0,008  Actinic keratosis treatment
0,212  0,011  Aldehyde dehydrogenase substrate
0,248  0,047  Antialcoholic
0,248  0,048  UGT1A1 substrate
0,203  0,003  Antiviral (Parainfluenza)
0,217  0,017  Antiviral (Poxvirus)
0,204  0,006  DOPA decarboxylase inhibitor
0,257  0,058  Calpain inhibitor
0,236  0,038  Antianorexic
0,223  0,026  Neurotensin receptor agonist
0,201  0,004  Antidote, heavy metal
0,213  0,017  Microtubule formation inhibitor
0,205  0,009  Antiviral (Influenza B)
0,228  0,034  Antiacne
0,239  0,046  Myocardial ischemia treatment
0,222  0,030  VEGF expression inhibitor
0,217  0,026  Antiprotozoal (Coccidial)
0,284  0,093  AR expression inhibitor
0,278  0,088  Antineoplastic (osteosarcoma)
0,204  0,016  Cathepsin G inhibitor
0,198  0,013  Gastric antisecretory
0,197  0,013  Vanilloid 1 agonist
0,291  0,106  Antileukemic
0,193  0,011  Carcinogenic, group 2A
0,278  0,096  Prostate cancer treatment
0,203  0,021  Antibacterial (Helicobacter pylori)
0,217  0,036  UGT2B15 substrate
0,213  0,033  UGT2B9 substrate
0,297  0,116  Calpain 2 inhibitor
0,183  0,004  Granulocyte macrophage colony stimulating factor agonist
0,186  0,006  Antileprosy
0,216  0,037  Prostate disorders treatment
0,266  0,087  Hypoxia-inducible factor 1 alpha inhibitor
0,183  0,005  Restless leg syndrome treatment
0,193  0,016  Antineoplastic alkaloid
0,180  0,003  Estrogen-related receptor beta agonist
0,222  0,046  Anticoagulant
0,194  0,018  Antihelmintic (Trematoda)
0,194  0,019  Beta amyloid protein antagonist
0,185  0,010  Heat shock protein 70 antagonist
0,205  0,030  Hemostatic
0,204  0,030  Cocaine dependence treatment
0,221  0,047  Age-related macular degeneration treatment
0,203  0,030  Antianemic
0,210  0,036  CNS active muscle relaxant
0,245  0,072  Antineoplastic (sarcoma)
0,222  0,050  Antianginal
0,203  0,032  Monophenol monooxygenase inhibitor
0,187  0,016  Contraceptive female
0,184  0,013  Caspase 3 inhibitor
0,217  0,047  Histone acetyltransferase inhibitor
0,181  0,012  Prolactin inhibitor
0,179  0,011  Electrolyte absorption antagonist
0,188  0,021  Anticataract
0,265  0,098  CYP2D6 substrate
0,241  0,075  Antiamyloidogenic
0,189  0,024  Movement disorders treatment
0,205  0,040  Lipid peroxidase inhibitor
0,171  0,007  Ornithine decarboxylase inhibitor
0,180  0,016  TRPA1 agonist
0,243  0,080  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,172  0,009  Toll-Like receptor 2 agonist
0,181  0,019  UGT2B1 substrate
0,175  0,013  ErbB-3 antagonist
0,193  0,031  Protein-tyrosine phosphatase 1B inhibitor
0,192  0,033  Cell wall synthesis inhibitor
0,175  0,017  Sphingosine 1-phosphate receptor 4 antagonist
0,192  0,034  SULT1A3 substrate
0,166  0,008  Acyl-CoA dehydrogenase inhibitor
0,181  0,023  SULT1A1 substrate
0,195  0,037  Genotoxic
0,161  0,005  Anticholelithogenic
0,175  0,020  Mediator release inhibitor
0,160  0,004  Potassium channel intermediate-conductance Ca-activated blocker
0,165  0,009  Glutathione S-transferase inhibitor
0,192  0,036  Interleukin 1 antagonist
0,162  0,008  Carbonic anhydrase VB inhibitor
0,183  0,028  Retinoprotector
0,166  0,013  Cell adhesion molecule inhibitor
0,164  0,010  UGT2B11 substrate
0,160  0,008  Leukotriene synthesis inhibitor
0,187  0,036  Anesthetic local
0,197  0,045  Aldehyde oxidase substrate
0,160  0,009  Interleukin 5 antagonist
0,195  0,044  Acute respiratory distress syndrome (ARDS) treatment
0,173  0,024  Bronchodilator
0,171  0,022  Gastritis treatment
0,167  0,019  DNA repair enzyme inhibitor
0,163  0,015  NADH dehydrogenase inhibitor
0,176  0,028  Aminopeptidase B inhibitor
0,164  0,016  Myasthenia Gravis treatment
0,280  0,133  CYP2C9 inhibitor
0,236  0,090  5 Hydroxytryptamine 1E antagonist
0,264  0,117  Antineoplastic (lung cancer)
0,170  0,023  Interleukin 8 antagonist
0,186  0,041  Pulmonary hypertension treatment
0,204  0,059  Sepsis treatment
0,153  0,008  Tourette's syndrome treatment
0,157  0,012  Paget's disease treatment
0,238  0,094  Amyotrophic lateral sclerosis treatment
0,167  0,024  UDP-glucose 4-epimerase inhibitor
0,147  0,005  Interferon inducer
0,157  0,014  Transcription factor NF kappa B stimulant
0,188  0,047  Antiparkinsonian, tremor relieving
0,148  0,007  Elastase 1 inhibitor
0,200  0,059  Antiviral (Hepatitis)
0,150  0,010  Prostaglandin EP2 antagonist
0,182  0,042  Skin whitener
0,180  0,041  NADPH oxidase inhibitor
0,172  0,033  Hearing loss treatment
0,178  0,038  CF transmembrane conductance regulator agonist
0,153  0,014  Carbonic anhydrase V inhibitor
0,154  0,016  Anabolic
0,164  0,026  Sphingosine 1-phosphate receptor 2 antagonist
0,143  0,007  Narcotic antagonist
0,152  0,016  Interleukin 1 beta converting enzyme inhibitor
0,183  0,047  Hexokinase inhibitor
0,191  0,055  Antipruritic
0,148  0,012  Lanosterol 14 alpha demethylase inhibitor
0,139  0,004  Glutamate (mGluR6) antagonist
0,170  0,036  Proteasome inhibitor
0,159  0,025  Antihelmintic (Fasciola)
0,168  0,035  Cathepsin H inhibitor
0,168  0,036  Farnesoid X receptor antagonist
0,146  0,014  Tocolytic
0,160  0,028  NAT2 substrate
0,141  0,009  NMDA receptor agonist
0,157  0,026  HDL-cholesterol increasing
0,136  0,005  Plasminogen activator inhibitor antagonist
0,238  0,109  CYP1A2 substrate
0,142  0,013  Carbonic anhydrase VA inhibitor
0,143  0,014  Glutamate (mGluR7) agonist
0,197  0,068  5 Hydroxytryptamine 3E antagonist
0,183  0,054  Antiviral (Hepatitis C)
0,168  0,041  Neuropeptide Y1 antagonist
0,150  0,023  Arylamine N-Acetyltransferase substrate
0,142  0,015  Peroxisome proliferator-activated receptor gamma agonist
0,144  0,017  Macrophage migration inhibitory factor inhibitor
0,159  0,032  Falcipain 3 inhibitor
0,151  0,025  Chronic obstructive bronchitis treatment
0,176  0,050  Thiol protease inhibitor
0,129  0,003  Glucose-6-phosphate isomerase inhibitor
0,130  0,005  Prostaglandin F2 alpha antagonist
0,129  0,006  Endocannabinoid uptake inhibitor
0,134  0,012  Glycine receptor antagonist
0,156  0,034  Menstruation disorders treatment
0,153  0,032  Antiprotozoal (Babesia)
0,177  0,056  Diuretic
0,163  0,042  Sphingosine 1-phosphate receptor 5 antagonist
0,228  0,107  Antineoplastic (pancreatic cancer)
0,125  0,005  Antidote, organophosphates
0,130  0,012  Biliverdin reductase inhibitor
0,124  0,006  Carbonic anhydrase XIV inhibitor
0,118  0,001  Carbonic anhydrase X inhibitor
0,118  0,001  Carbonic anhydrase VIII inhibitor
0,153  0,037  5-Lipoxygenase inhibitor
0,185  0,069  LDLR expression enhancer
0,150  0,034  Alcohol dehydrogenase substrate
0,213  0,097  Neuropeptide Y2 antagonist
0,130  0,016  NAT1 substrate
0,126  0,011  Antiviral (Hepatitis A)
0,118  0,004  VEGFR2 expression inhibitor
0,121  0,007  CD45 antagonist
0,154  0,041  Antiprotozoal (Amoeba)
0,148  0,035  Antiviral (Papilloma)
0,127  0,014  Argininosuccinate synthase inhibitor
0,227  0,115  Antineoplastic (multiple myeloma)
0,159  0,047  Antifungal (Cryptococcus)
0,140  0,029  Creatine kinase inhibitor
0,188  0,076  Wound healing agent
0,126  0,015  Sphingosine 1-phosphate receptor 4 agonist
0,139  0,028  Electron transport complex I inhibitor
0,155  0,046  Antiprotozoal (Trichomonas)
0,161  0,052  Renal failure treatment
0,128  0,019  Antifungal (Candida)
0,138  0,030  HIV-1 integrase (Overall Integration) inhibitor
0,218  0,111  Antineoplastic (bladder cancer)
0,149  0,042  Growth stimulant
0,124  0,017  ATPase (Vacuolar H+) inhibitor
0,111  0,004  Ryanodine receptor antagonist
0,147  0,040  Carcinogenic, group 2B
0,189  0,082  Antiviral (Influenza)
0,111  0,005  Prostaglandin agonist
0,138  0,032  Potassium channel (Ca-activated) activator
0,121  0,015  Hyperparathyroidism treatment
0,121  0,014  Caspase 7 inhibitor
0,236  0,130  CYP3A4 inhibitor
0,119  0,014  T cell inhibitor
0,166  0,062  Antiviral (Influenza A)
0,153  0,048  Pregnane X receptor agonist
0,123  0,019  Antiprotozoal activity enhancer
0,108  0,004  Lysophosphatidic acid 3 receptor antagonist
0,113  0,010  GABA B receptor agonist
0,124  0,021  Selectin antagonist
0,118  0,016  Leukotriene antagonist
0,109  0,007  Glutamate (mGluR7) antagonist
0,140  0,038  Protein kinase C gamma inhibitor
0,141  0,039  Shock treatment
0,107  0,006  Nitric oxide donor
0,110  0,009  Antimycoplasmal
0,119  0,019  Vanilloid agonist
0,136  0,036  Carbonic anhydrase XV inhibitor
0,158  0,058  Mannose-6-phosphate isomerase inhibitor
0,119  0,020  Bile acid receptor antagonist
0,145  0,045  Autism spectrum disorders treatment
0,124  0,025  Antiviral (Rhinovirus)
0,120  0,021  Keratolytic
0,248  0,149  Toll-Like receptor 7 agonist
0,132  0,033  Sphingomyelinase inhibitor
0,146  0,047  Histone deacetylase class III inhibitor
0,189  0,091  Anticonvulsant
0,164  0,066  Cytidine deaminase inhibitor
0,107  0,009  Thromboxane antagonist
0,130  0,033  Breast cancer-resistant protein inhibitor
0,115  0,019  Na+ K+ transporting ATPase inhibitor
0,101  0,005  Leukotriene A4 hydrolase inhibitor
0,141  0,046  Retinopathy treatment
0,202  0,106  Acute neurologic disorders treatment
0,171  0,075  Macular degeneration treatment
0,164  0,069  Cystic fibrosis treatment
0,103  0,008  Oleamide hydrolase inhibitor
0,138  0,043  GABA receptor agonist
0,143  0,050  Adenylate cyclase inhibitor
0,108  0,015  Antiemphysemic
0,105  0,012  Uterine relaxant
0,107  0,014  Maillard reaction inhibitor
0,133  0,041  Xanthine oxidase inhibitor
0,106  0,014  NMDA receptor glycine site agonist
0,105  0,014  Protease 3C (Human rhinovirus) inhibitor
0,108  0,017  Narcolepsy treatment
0,123  0,033  Alcohol dehydrogenase inhibitor
0,209  0,119  Antiosteoporotic
0,228  0,138  Thyroid hormone antagonist
0,098  0,008  Thromboxane A2 antagonist
0,103  0,013  Phospholipase D inhibitor
0,099  0,009  SULT2A1 substrate
0,111  0,023  Aminopeptidase I inhibitor
0,110  0,022  Lipase inhibitor
0,098  0,010  Exportin-1 inhibitor
0,131  0,043  Antischistosomal
0,150  0,062  Cytokine production inhibitor
0,132  0,044  Chelator
0,099  0,012  Gaucher disease treatment
0,193  0,106  Antineoplastic (cervical cancer)
0,102  0,016  Ornithine carbamoyltransferase inhibitor
0,124  0,038  Mental retardation treatment
0,093  0,008  Thromboxane synthase inhibitor
0,107  0,022  Epoxide hydrolase inhibitor
0,217  0,133  12-Lipoxygenase inhibitor
0,103  0,019  Sleep apnea treatment
0,190  0,106  Antiprotozoal (Leishmania)
0,146  0,063  Neurotrophic factor
0,092  0,010  MDM2 inhibitor
0,092  0,010  Leukocyte elastase inhibitor
0,118  0,036  Posttraumatic stress disorder treatment
0,083  0,002  Lysophosphatidic acid receptor 3 agonist
0,099  0,017  Vanilloid 4 agonist
0,087  0,005  Adenylate cyclase 1 inhibitor
0,086  0,005  Membrane dipeptidase inhibitor
0,085  0,004  Kynurenine 3 monooxygenase inhibitor
0,086  0,005  Pregnane X receptor antagonist
0,084  0,004  Prostacyclin agonist
0,151  0,071  Antiischemic, cerebral
0,122  0,043  Antiprotozoal (Toxoplasma)
0,081  0,002  Lysophosphatidic acid receptor 1 agonist
0,218  0,140  Thyroid hormone beta antagonist
0,154  0,076  Neuropathy treatment
0,081  0,004  Glutamate (mGluR8) agonist
0,086  0,009  Alpha-mannosidase inhibitor
0,199  0,124  Antineoplastic (ovarian cancer)
0,191  0,117  Antineoplastic (renal cancer)
0,079  0,005  Lysophosphatidic acid 2 receptor antagonist
0,206  0,132  Antiepileptic
0,081  0,007  AICAR transformylase inhibitor
0,078  0,005  Benzodiazepine antagonist
0,081  0,009  Adenosine deaminase inhibitor
0,117  0,045  Dementia treatment
0,086  0,014  Leukotriene B4 antagonist
0,118  0,047  Sulfotransferase substrate
0,105  0,035  NAD(P)H dehydrogenase (quinone) inhibitor
0,127  0,057  Interleukin 1b antagonist
0,072  0,003  Prostaglandin F2 alpha agonist
0,078  0,009  Mannosidase inhibitor
0,113  0,045  Vascular dementia treatment
0,102  0,035  Chymotrypsin inhibitor
0,120  0,052  MAO A inhibitor
0,076  0,009  Leukotriene C antagonist
0,071  0,004  Epoxide hydrolase 1 inhibitor
0,137  0,070  Nav1.6 sodium channel blocker
0,071  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,070  0,004  Prostaglandin D2 agonist
0,194  0,129  Antineoplastic (melanoma)
0,071  0,007  Arginase inhibitor
0,071  0,007  Cytokine production stimulant
0,093  0,029  Amidase inhibitor
0,068  0,005  Kainate receptor agonist
0,135  0,072  Calcium channel blocker
0,150  0,087  Prostatic (benign) hyperplasia treatment
0,068  0,005  Guanylate cyclase inhibitor
0,104  0,042  Histamine N-methyltransferase inhibitor
0,080  0,018  Peroxisome proliferator-activated receptor alpha agonist
0,077  0,016  Lipocortins synthesis agonist
0,225  0,164  Antineoplastic (breast cancer)
0,086  0,026  Peroxisome proliferator-activated receptor gamma antagonist
0,088  0,028  Acetylcholine M5 receptor agonist
0,080  0,020  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,082  0,022  Caspase 9 inhibitor
0,061  0,003  Calcium-independent phospholipase A2 inhibitor
0,081  0,023  Prostaglandin antagonist
0,089  0,031  Phenylalanine 4-hydroxylase inhibitor
0,067  0,009  Dihydropteroate synthase inhibitor
0,072  0,015  Potassium channel Kv1.3 blocker
0,098  0,041  Acetylcholine nicotinic antagonist
0,066  0,010  Phosphoglycerate kinase inhibitor
0,088  0,032  Calcium channel L-type blocker
0,071  0,015  Purinergic P2Y antagonist
0,066  0,010  GABA B receptor antagonist
0,064  0,008  GABA uptake inhibitor
0,072  0,016  Acetyl-CoA transferase 2 inhibitor
0,080  0,025  Purinergic P2X1 antagonist
0,059  0,004  Elastase 3B inhibitor
0,059  0,004  Elastase 3A inhibitor
0,059  0,004  Elastase 2B inhibitor
0,066  0,011  Glutamate (mGluR4) antagonist
0,106  0,051  Nitric-oxide synthase inhibitor
0,087  0,033  Sphingosine 1-phosphate receptor antagonist
0,081  0,027  Beta adrenoreceptor antagonist
0,068  0,015  Squalene epoxidase inhibitor
0,142  0,089  Aldose reductase substrate
0,152  0,098  3C-like protease (Human coronavirus) inhibitor
0,074  0,022  Beta 1 adrenoreceptor antagonist
0,194  0,142  Antidiabetic (type 2)
0,073  0,021  Antimetabolite
0,070  0,018  Sphingosine 1-phosphate receptor 1 antagonist
0,063  0,011  Geranyltranstransferase inhibitor
0,087  0,036  CDC25A inhibitor
0,061  0,009  Prostacyclin antagonist
0,092  0,041  D-Ala-D-Ala ligase inhibitor
0,055  0,005  Methionyl aminopeptidase 1 inhibitor
0,062  0,012  Glutamate (mGluR group III) antagonist
0,056  0,006  Purinergic P2Y12 antagonist
0,060  0,010  Dihydrofolate reductase inhibitor
0,051  0,002  Carbonic anhydrase XI inhibitor
0,067  0,018  Antiviral (Herpesvirus 3, Human)
0,090  0,041  Thioredoxin reductase inhibitor
0,129  0,081  Antineoplastic (squamous cell carcinoma)
0,061  0,013  Retinoid X receptor agonist
0,069  0,021  Glycine transporter 2 inhibitor
0,092  0,045  Inducible nitric-oxide synthase inhibitor
0,053  0,005  Prostaglandin E2 agonist
0,115  0,068  Antitussive
0,072  0,025  Corticotropin releasing factor 2 receptor antagonist
0,064  0,017  Heparanase inhibitor
0,052  0,005  Prostaglandin EP4 agonist
0,051  0,005  Elastase 2 inhibitor
0,051  0,005  Elastase 2A inhibitor
0,106  0,060  Urease inhibitor
0,145  0,099  Dual specificity phosphatase inhibitor
0,069  0,023  Elastase inhibitor
0,070  0,024  GP IIb/IIIa receptor antagonist
0,049  0,003  Calcium-dependent phospholipase A2 inhibitor
0,051  0,005  Prostaglandin EP2 agonist
0,063  0,018  Carbonic anhydrase VII inhibitor
0,055  0,010  Glutamate (mGluR3) antagonist
0,061  0,016  Sphingosine 1-phosphate receptor agonist
0,055  0,010  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,064  0,020  Prolyl endopeptidase inhibitor
0,074  0,029  Carbonic anhydrase stimulant
0,053  0,008  Hypoxanthine phosphoribosyltransferase inhibitor
0,060  0,015  Dopamine beta hydroxylase inhibitor
0,080  0,036  Phosphodiesterase III inhibitor
0,079  0,036  Potassium channel (Tandem pore domain) blocker
0,090  0,047  mTOR complex 2 inhibitor
0,059  0,016  5-Alpha-reductase inhibitor
0,081  0,038  Benzodiazepine agonist
0,045  0,002  Thromboxane A2 agonist
0,050  0,007  HMG CoA reductase inhibitor
0,067  0,025  Postcoital contraceptive
0,051  0,009  Leukotriene C4 antagonist
0,085  0,043  Antibiotic
0,065  0,023  Epithelial sodium channel blocker
0,050  0,008  Vanilloid 3 antagonist
0,059  0,018  Cholesterol esterase inhibitor
0,048  0,008  Leukotriene B4 receptor 1 antagonist
0,086  0,046  CC chemokine 5 receptor agonist
0,104  0,064  Antifungal (Aspergillus)
0,114  0,074  Constipation treatment
0,046  0,006  Glutamate (mGluR3) agonist
0,079  0,039  S-adenosyl-L-methionine decarboxylase inhibitor
0,043  0,004  Glucosylceramidase stimulant
0,043  0,004  Toll-Like receptor 4 agonist
0,219  0,181  Antiasthmatic
0,057  0,019  Fructose-1,6-bisphosphatase inhibitor
0,046  0,009  GABA transporter 3 inhibitor
0,061  0,023  Immunoglobulin Fc receptor antagonist
0,068  0,031  Calcium channel P-type blocker
0,046  0,009  Melatonin receptor 1A agonist
0,141  0,104  Dual specificity phosphatase 3 inhibitor
0,059  0,022  HCV NS3/NS4A protease inhibitor
0,084  0,048  Metalloproteinase-2 inhibitor
0,056  0,020  CC chemokine 4 receptor antagonist
0,052  0,015  Angiotensin AT1 receptor antagonist
0,131  0,095  Acetylcholine M1 receptor antagonist
0,066  0,030  Sphingosine 1-phosphate receptor 3 antagonist
0,105  0,070  5 Hydroxytryptamine 3A agonist
0,040  0,005  Hedgehog signaling activator
0,050  0,015  Inosine monophosphate dehydrogenase inhibitor
0,074  0,039  Protein kinase C beta inhibitor
0,056  0,021  Thymidylate synthase inhibitor
0,061  0,026  Adenine nucleotide translocase inhibitor
0,046  0,011  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,044  0,010  Benzodiazepine receptor peripheral-type antagonist
0,040  0,006  Excitatory amino acid transporter 2 inhibitor
0,084  0,050  Topoisomerase II alpha inhibitor
0,048  0,015  Retinoid X receptor antagonist
0,151  0,118  Antineoplastic (glioblastoma multiforme)
0,060  0,027  Nicotinic alpha3beta2 receptor antagonist
0,045  0,012  Peptide deformylase inhibitor
0,036  0,004  Isoleucine-tRNA ligase inhibitor
0,048  0,016  Farnesoid X receptor agonist
0,043  0,011  ATP citrate lysase inhibitor
0,058  0,026  Glucose-6-phosphate translocase inhibitor
0,148  0,117  Pyruvate kinase inhibitor
0,038  0,007  Prostaglandin H2 antagonist
0,043  0,011  Cholesterol ester transfer protein antagonist
0,042  0,010  Prostaglandin EP4 antagonist
0,047  0,015  Squalene synthetase inhibitor
0,058  0,026  Beta 2 adrenoreceptor antagonist
0,036  0,005  Vanilloid 2 agonist
0,045  0,014  Caspase 2 inhibitor
0,081  0,050  Nicotinic alpha4beta2 receptor antagonist
0,049  0,018  Dopamine D5 agonist
0,037  0,009  Purinergic P2Y15 antagonist
0,057  0,030  Sphingosine 1-phosphate receptor 5 agonist
0,096  0,069  Protease inhibitor
0,034  0,007  Glutamate (mGluR1a) agonist
0,055  0,028  Metalloproteinase-3 inhibitor
0,046  0,020  Histone deacetylase 7 inhibitor
0,093  0,067  Phosphodiesterase 6D inhibitor
0,044  0,019  Cholesterol absorption inhibitor
0,044  0,019  DNA gyrase subunit B inhibitor
0,065  0,040  Transcription factor RelA inhibitor
0,039  0,015  Angiotensin II receptor antagonist
0,053  0,029  Bombesin 2 receptor antagonist
0,047  0,023  Nerve growth factor antagonist
0,036  0,012  Lysine carboxypeptidase inhibitor
0,039  0,016  Retinoid X alpha receptor antagonist
0,030  0,006  Lysophosphatidic acid 1 receptor antagonist
0,046  0,024  Sphingosine 1-phosphate receptor 1 agonist
0,026  0,003  Thromboxane agonist
0,057  0,035  Matrix metalloproteinase (membrane-type) inhibitor
0,057  0,035  Glucosylceramidase inhibitor
0,032  0,010  Nicotinic acid receptor 2 antagonist
0,039  0,017  Carnitine palmitoyltransferase inhibitor
0,036  0,015  Liver X receptor beta antagonist
0,030  0,008  GRP78 expression inhibitor
0,027  0,006  Excitatory amino acid transporter 3 inhibitor
0,038  0,018  Carnitine palmitoyltransferase 1 inhibitor
0,046  0,026  Histamine H2 receptor agonist
0,056  0,036  GABA receptor antagonist
0,060  0,040  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,039  0,018  Sirtuin 2 inhibitor
0,049  0,029  Microtubule stabilization
0,031  0,011  Thyroid hormone agonist
0,038  0,018  Peroxisome proliferator-activated receptor delta agonist
0,047  0,027  Dihydroorotase inhibitor
0,060  0,040  Cathepsin E inhibitor
0,067  0,048  Potassium channel large-conductance Ca-activated activator
0,025  0,005  Antibiotic Anthracycline-like
0,074  0,054  CYP2A6 inhibitor
0,059  0,040  Botulinum neurotoxin type A inhibitor
0,066  0,047  Matrix metalloproteinase inhibitor
0,038  0,019  Glutamate (mGluR8) antagonist
0,044  0,025  Heme oxygenase inhibitor
0,024  0,006  Estrogen-related receptor gamma agonist
0,026  0,007  Neuraminidase (Influenza B) inhibitor
0,040  0,021  Nicotinic acid receptor agonist
0,113  0,095  Alkaline phosphatase inhibitor
0,055  0,037  Ribonucleoside-diphosphate reductase inhibitor
0,056  0,038  Ribonucleotide reductase inhibitor
0,024  0,006  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,032  0,014  Leukotriene D4 antagonist
0,054  0,036  GABA A receptor antagonist
0,054  0,036  Acetyl-CoA transferase inhibitor
0,104  0,086  MAO inhibitor
0,030  0,013  Calcium-sensing receptor agonist
0,038  0,020  Ceramide glucosyltransferase inhibitor
0,035  0,017  Prostaglandin EP3 antagonist
0,038  0,021  Retinoid X alpha receptor agonist
0,087  0,070  ABCA1 expression enhancer
0,057  0,041  Dopamine uptake inhibitor
0,076  0,059  MAP kinase kinase 7 inhibitor
0,048  0,032  Aldosterone antagonist
0,028  0,012  Acid ceramidase inhibitor
0,115  0,098  Histone deacetylase SIRT1 inhibitor
0,084  0,068  Bromodomain-containing protein 2 inhibitor
0,106  0,090  Transcription factor STAT6 inhibitor
0,040  0,024  VCAM-1 antagonist
0,032  0,016  Uridine phosphorylase inhibitor
0,040  0,024  VCAM antagonist
0,140  0,124  UDP-glucuronosyltransferase substrate
0,043  0,027  Glutamate (mGluR1a) antagonist
0,063  0,047  Beta 3 adrenoreceptor antagonist
0,019  0,004  Calcineurin inhibitor
0,056  0,041  Fatty acid synthase inhibitor
0,023  0,008  Toll-Like receptor 8 agonist
0,049  0,034  Topoisomerase II beta inhibitor
0,021  0,007  Methylmalonyl-CoA mutase inhibitor
0,079  0,065  GABA A receptor agonist
0,058  0,043  HIV-1 integrase (Strand Transfer) inhibitor
0,019  0,004  Glutamate (mGluR6) agonist
0,023  0,009  Retinoid X beta receptor antagonist
0,062  0,048  Neutrophil collagenase inhibitor
0,093  0,080  AMP-activated protein kinase stimulant
0,027  0,014  Glutamate (mGluR1) agonist
0,021  0,008  Ileal bile acid transport inhibitor
0,020  0,007  Vitamin D receptor agonist
0,052  0,039  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,041  0,029  Plasmepsin II inhibitor
0,023  0,011  Inosine monophosphate dehydrogenase 2 inhibitor
0,026  0,014  Complement factor 1s inhibitor
0,022  0,010  Caspase 8 inhibitor
0,034  0,022  Carboxypeptidase B inhibitor
0,042  0,031  Carbonic anhydrase IV inhibitor
0,020  0,008  Telomerase stimulant
0,029  0,017  DNA polymerase III inhibitor
0,041  0,030  Oxytocin agonist
0,034  0,023  Calcitonin receptor agonist
0,019  0,009  Vesicular glutamate transport inhibitor
0,064  0,054  Antihemophilic
0,020  0,009  G-protein-coupled receptor 120 agonist
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,078  0,068  Antiviral (Trachoma)
0,072  0,063  Antineoplastic antibiotic
0,105  0,096  Tubulin antagonist
0,081  0,071  Hematopoietic
0,033  0,024  Free fatty acid receptor 1 antagonist
0,097  0,088  Calcium channel (voltage-sensitive) blocker
0,015  0,006  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,104  0,096  Cyclooxygenase 1 inhibitor
0,056  0,047  Androgen agonist
0,017  0,009  Purinergic P2Y1 agonist
0,072  0,065  Antitreponemal
0,018  0,010  Excitatory amino acid transporter 1 inhibitor
0,037  0,030  Urate transporter 1 inhibitor
0,035  0,028  Tryptophan 5 hydroxylase inhibitor
0,040  0,033  Glutamate (mGluR group III) agonist
0,056  0,050  Potassium channel (Ca-activated) blocker
0,011  0,004  Folate transporter 1 inhibitor
0,039  0,032  Thymidine kinase inhibitor
0,041  0,035  Guanylate cyclase stimulant
0,023  0,017  Fructose-1,6-bisphosphatase 1 inhibitor
0,054  0,048  Calcium channel T-type blocker
0,067  0,062  Metalloproteinase-9 inhibitor
0,033  0,029  Adenosine uptake inhibitor
0,028  0,023  Trypsin II inhibitor
0,026  0,022  LFA antagonist
0,051  0,046  Angiotensin-converting enzyme inhibitor
0,047  0,042  Aldose reductase inhibitor
0,041  0,036  Phosphorylase inhibitor
0,014  0,010  Angiotensin AT1B receptor antagonist
0,034  0,030  Factor XIIIa inhibitor
0,054  0,050  Collagenase 3 inhibitor
0,144  0,140  Aryl hydrocarbon receptor agonist
0,019  0,016  Antibiotic Quinolone-like
0,037  0,034  Liver X receptor alpha agonist
0,021  0,018  Prostaglandin D2 antagonist
0,017  0,014  Antibiotic Trimethoprim-like
0,018  0,015  Granulocyte colony stimulating factor receptor agonist
0,032  0,029  Kainate receptor 2 antagonist
0,020  0,017  GABA transporter inhibitor
0,016  0,014  Aminopeptidase A inhibitor
0,020  0,017  Corticosteroid-like
0,054  0,052  Sphingosine kinase inhibitor
0,099  0,097  Cholinergic antagonist
0,090  0,088  Beta glucuronidase inhibitor
0,152  0,151  Antineoplastic enhancer
0,005  0,003  P2 nucleoside transporter inhibitor
0,007  0,006  Phosphoribosylglycinamide formyltransferase inhibitor
0,012  0,010  Antineoplastic (insulinoma)
0,017  0,016  5-Alpha-reductase 2 inhibitor
0,113  0,112  Psychosexual dysfunction treatment
0,031  0,030  Glutamate (mGluR4) agonist
0,152  0,151  Antiviral (HIV)

